Larson Financial Group’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Larson Financial Group’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-713	Closed	-$19.2K	–	3118
2024 Q4	$19.2K	Hold	713	–	–	﹤0.01%	1234
2024 Q3	$20.6K	Buy	+713	New	+$20.4K	﹤0.01%	1200
2023 Q1	–	Sell	-1,008	Closed	-$27.7K	–	1568
2022 Q4	$27.7K	Buy	1,008 +4	+0.4%	+$106	﹤0.01%	629
2022 Q3	$24K	Buy	+1,004	New	+$26K	﹤0.01%	591

Other funds holding FTXH

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Larson Financial Group's FTXH Position: Q1 2025 in Review

Larson Financial Group sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2025, closing a stake of 713 shares — an estimated $19.2K sold.

Larson Financial Group first reported a position in FTXH in Q3 2022 and held it in 4 quarters. The position peaked at $27.7K in Q4 2022. 20 funds tracked by Wall St. Rank hold FTXH as of Q1 2025.

Larson Financial Group reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
Larson Financial Group sold 713 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2025, an estimated $19.2K.
Larson Financial Group first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2022 and held it in 4 quarters.
Larson Financial Group's First Trust Nasdaq Pharmaceuticals ETF position peaked at $27.7K in Q4 2022.
20 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2025.

Based on Larson Financial Group's 13F filing for Q1 2025, filed 2 May 2025.